Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV

Simple item page
dc.contributor.authorMaponga, Tongai Gibson.en_ZA
dc.contributor.authorGlashoff, Richard H.en_ZA
dc.contributor.authorVermeulen, Hannalien_ZA
dc.contributor.authorRobertson, Barbaraen_ZA
dc.contributor.authorBurmeister, Seanen_ZA
dc.contributor.authorBernon, Marcen_ZA
dc.contributor.authorOmoshoro-Jones, Jonesen_ZA
dc.contributor.authorRuff, Paulen_ZA
dc.contributor.authorNeugut, Alfred I.
dc.contributor.authorJacobson, Judith S.en_ZA
dc.contributor.authorPreiser, Wolfgangen_ZA
dc.contributor.authorAndersson, Monique I.en_ZA
dc.date.accessioned2020-07-27T07:06:20Z
dc.date.available2020-07-27T07:06:20Z
dc.date.issued2020-07-13
dc.date.updated2020-07-19T03:45:28Z
dc.descriptionCITATION: Maponga, T. G., et al. 2020. Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV. BMC Gastroenterology, 20:226, doi:10.1186/s12876-020-01372-2.
dc.descriptionThe original publication is available at https://bmcgastroenterol.biomedcentral.com
dc.description.abstractBackground: Patients co-infected with hepatitis B virus (HBV) and the human immunodeficiency virus (HIV) are at risk of developing hepatocellular carcinoma (HCC). In sub-Saharan Africa, the overlap between high HIV and HBV prevalence may increase the incidence of HCC. This study investigated the impact of HBV/HIV co-infection on age at presentation and survival of HCC. Methods: Ethical approval was obtained to recruit, following informed written consent, patients diagnosed with HCC at oncology units at four South African hospitals. Between December 2012 and August 2015, patients newly diagnosed with HCC were recruited and provided demographic and clinical data and blood specimens. Patients were tested for HBV, hepatitis C virus (HCV) and HIV. Survival data was available for a subset of patients. Results: Of 107 HCC cases, 83 (78%) were male. Median age was 46 years (range 18 to 90 years), 68/106 (64%) were HBsAg-positive, and 22/100 (22%) were HIV infected. Among HBV surface antigen (HBsAg)-positive HCC cases, 18/66 (27%) were HIV-infected compared to 3/34 (9%) among those that were HBsAg-negative (p = 0.04). A greater proportion of HBV/HIV co-infected cases were female than HBV mono-infected (6/18, 33% vs 6/47, 13%; p = 0.005). In addition, HBV/HIV co-infected females presented at a younger mean age (36.8 years) than HBV mono-infected women (50.5 years) (p = 0.09). Median survival was 82 days among the HIV-infected HCC patients compared to 181 days among those without HIV (p = 0.15). Conclusions: HCC is an important complication in the HIV/HBV infected patient. HIV-positive patients presented with HCC at a younger age than HIV-negative patients, this effect appears to be greater in women. These data provide more evidence supporting the call to address. HCC as a cause of morbidity and mortality in the HBV/HIV co-infected patient population. (281 words).
dc.description.urihttps://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-020-01372-2
dc.description.versionPublisher's version
dc.format.extent9 pages
dc.identifier.citationMaponga, T. G., et al. 2020. Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV. BMC Gastroenterology, 20:226, doi:10.1186/s12876-020-01372-2
dc.identifier.issn1471-230X (online)
dc.identifier.otherdoi:10.1186/s12876-020-01372-2
dc.identifier.urihttp://hdl.handle.net/10019.1/108729
dc.language.isoen_ZAen_ZA
dc.publisherBMC (part of Springer Nature)
dc.rights.holderAuthors retain copyright
dc.subjectHepatitis B infection
dc.subjectHIV infectionsen_ZA
dc.subjectHepatocellular carcinomaen_ZA
dc.titleHepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIVen_ZA
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
gibson_hepatitis_2020.pdf
Size:
573.76 KB
Format:
Adobe Portable Document Format
Description:
Download article
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Research Articles (Medical Virology)